Delivery Order SPE2DB24D8002-SPE2DB24FJMRL
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,932.87 firm fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period through May 6, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support...
This federal contract award, valued at $4,508.95, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of August 28, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract worth $6,681.60 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4563200640 - VRAYLAR 3 MG CAPSULE 30S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Dakota Drug, Inc. The contract has an ultimate completion date of January 2, 2024 and does not...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a potential value of $4,889.89 and a completion date of December 22, 2023. Under this contract, Dakota Drug, Inc. will provide the DLA Troop Support Medical with VRAYLAR 6 MG CAPSULE 30S, a pharmaceutical product. This delivery order is issued against Dakota Drug's existing blanket purchase...
This federal contract award, valued at $8,561.54, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a firm-fixed price delivery order for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This federal contract award, with an ID of SPE2DB24D8003|SPE2DB25FJTUH, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,608.06 firm fixed-price delivery order is for the supply of 4.5 mg Vraylar capsules. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This is a delivery order for $2,762.65 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The order is for the pharmaceutical product Vraylar 4.5 mg capsule, with a performance period ending on April 9, 2024. The contract is a firm fixed-price arrangement without any set-aside designation. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the federal government, particularly the...
This federal contract award, identified as SPE2DB24D8003|SPE2DB24FJTNA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract involves the delivery of pharmaceutical products, specifically the medication VRAYLAR 3 MG CAPSULE 30S, with a ceiling value of $7,338.83. This delivery order contract has a firm fixed-price pricing type and does not utilize any set-aside designations. Dakota Drug, Inc. is a small disadvantaged...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4565192015 VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $1,894.42 and a period of performance through July 19, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a comprehensive range of pharmaceutical products, medical supplies, and healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product VRAYLAR 6 MG CAPSULE 30S. The contract has a ceiling value of $13,656.06 and an ultimate completion date of April 9, 2024. The contract was awarded on April 8, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is a prime contractor with over two...